JPMorgan raised the firm’s price target on Oxford Biomedica (OXBDF) to 450 GBp from 305 GBp and keeps a Neutral rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.